The IBN SINA Pharmaceutical Industry PLC (DSE: IBNSINA)
Bangladesh
· Delayed Price · Currency is BDT
291.80
-6.40 (-2.15%)
At close: Nov 14, 2024
IBNSINA Revenue
In the fiscal year ending June 30, 2024, The IBN SINA Pharmaceutical Industry had annual revenue of 11.37B BDT with 24.61% growth. The IBN SINA Pharmaceutical Industry had revenue of 2.99B in the quarter ending June 30, 2024, with 20.30% growth.
Revenue
11.37B
Revenue Growth
+24.61%
P/S Ratio
0.80
Revenue / Employee
2.71M
Employees
4,000
Market Cap
9.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 11.37B | 2.25B | 24.61% |
Jun 30, 2023 | 9.13B | 645.51M | 7.61% |
Jun 30, 2022 | 8.48B | 1.10B | 14.96% |
Jun 30, 2021 | 7.38B | 1.18B | 19.13% |
Jun 30, 2020 | 6.19B | 927.67M | 17.62% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition